- Home
- RDHL vs ISPC Comparison
RDHL vs ISPC Comparison
Compare RDHL & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- ISPC
- Stock Information
- Founded
- RDHL 2009
- ISPC 2009
- Country
- RDHL Israel
- ISPC United States
- Employees
- RDHL N/A
- ISPC N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- RDHL Health Care
- ISPC Health Care
- Exchange
- RDHL Nasdaq
- ISPC Nasdaq
- Market Cap
- RDHL 3.9M
- ISPC 4.6M
- IPO Year
- RDHL N/A
- ISPC 2021
- Fundamental
- Price
- RDHL $1.34
- ISPC $0.82
- Analyst Decision
- RDHL
- ISPC
- Analyst Count
- RDHL 0
- ISPC 0
- Target Price
- RDHL N/A
- ISPC N/A
- AVG Volume (30 Days)
- RDHL 142.3K
- ISPC 1.3M
- Earning Date
- RDHL 09-02-2025
- ISPC 08-14-2025
- Dividend Yield
- RDHL N/A
- ISPC N/A
- EPS Growth
- RDHL N/A
- ISPC N/A
- EPS
- RDHL N/A
- ISPC N/A
- Revenue
- RDHL $8,042,999.00
- ISPC $5,908,088.00
- Revenue This Year
- RDHL $381.91
- ISPC $35.93
- Revenue Next Year
- RDHL N/A
- ISPC N/A
- P/E Ratio
- RDHL N/A
- ISPC N/A
- Revenue Growth
- RDHL 23.17
- ISPC N/A
- 52 Week Low
- RDHL $1.06
- ISPC $0.70
- 52 Week High
- RDHL $12.50
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- RDHL 42.30
- ISPC 35.91
- Support Level
- RDHL $1.31
- ISPC $1.13
- Resistance Level
- RDHL $1.48
- ISPC $1.50
- Average True Range (ATR)
- RDHL 0.09
- ISPC 0.20
- MACD
- RDHL 0.03
- ISPC -0.06
- Stochastic Oscillator
- RDHL 65.48
- ISPC 11.11
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.